VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AIFU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AIFUAIFU Inc.
$46.46$551M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAIFUFinancials

AIFU Inc. (AIFU) Financials

21Y historyFree accessUpdated daily

The company's profitability is under severe pressure, evidenced by a 2023Q4 net loss of $27.2 million and a combined ratio that has deteriorated to 97.3%.

AIFU Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05
Revenue3.2B556.57M1.81B3.2B2.78B3.27B3.27B3.71B3.47B4.09B4.08B2.46B2.15B1.76B1.59B1.52B1.23B1.15B843.96M448.79M252.55M143.74M
Revenue Growth %14.98%-69.23%-43.45%14.98%-14.96%0.09%-11.81%6.76%-15.1%0.14%66.03%14.38%22.37%10.78%4.58%22.91%6.85%36.84%88.05%77.7%75.7%-
Medical Costs & Claims2.15B282.3M1.11B2.15B1.8B2.12B2.21B2.48B2.35B3.06B3.11B1.86B1.62B1.29B1.09B796.84M541.24M579.91M436.8M232.89M136.32M65.77M
Medical Cost Ratio %67.08%50.72%61.52%67.08%64.55%64.66%67.74%67.01%67.58%74.83%76.09%75.5%75.12%73.61%68.46%52.54%43.86%50.22%51.76%51.89%53.98%45.76%
Gross Profit1.05B274.27M695.97M1.05B986.01M1.16B1.05B1.22B1.13B1.03B976.28M602.48M534.85M463.65M500.31M719.83M692.7M574.94M407.16M215.9M116.24M77.97M
Gross Margin %32.92%49.28%38.48%32.92%35.45%35.34%32.26%32.99%32.42%25.17%23.91%24.5%24.88%26.39%31.54%47.46%56.14%49.78%48.24%48.11%46.02%54.24%
Gross Profit Growth %--60.59%-33.9%6.79%-14.7%9.64%-13.76%8.65%9.35%5.41%62.04%12.64%15.36%-7.33%-30.5%3.92%20.48%41.21%88.59%85.74%49.09%-
Operating Expenses857.15M1.87B1.13B857.15M817.34M854.04M752.09M753.19M699.5M755.93M984.75M574.03M503.95M445.67M434.48M1.47B298.17M248.74M196.41M77.8M64.95M84.42M
OpEx / Revenue %26.8%336.61%62.57%26.8%29.38%26.11%23.01%20.32%20.15%18.49%24.12%23.34%23.44%25.36%27.39%96.83%24.16%21.54%23.27%17.34%25.72%58.73%
Depreciation & Amortization05.33M29.31M34.05M19.47M18.39M17.94M17.22M26.78M47.28M33.72M29.95M45.06M44.92M41.63M53.82M52.07M28.45M9.48M3.52M2.02M637.81K
Combined Ratio %93.88%387.33%124.1%93.88%93.94%90.77%90.75%87.34%87.74%93.32%100.21%98.84%98.56%98.98%95.85%149.37%68.03%71.75%75.03%69.23%79.69%104.49%
Operating Income195.82M-1.6B-435.84M195.82M168.68M301.9M302.19M469.36M425.74M273.14M-8.47M28.45M30.9M17.99M65.83M-748.77M394.52M326.2M210.75M138.1M51.28M-6.46M
Operating Margin %6.12%-287.33%-24.1%6.12%6.06%9.23%9.25%12.66%12.26%6.68%-0.21%1.16%1.44%1.02%4.15%-49.37%31.97%28.25%24.97%30.77%20.31%-4.49%
Operating Income Growth %--266.92%-322.57%16.1%-44.13%-0.09%-35.62%10.25%55.87%3326.27%-129.76%-7.93%71.79%-72.68%108.79%-289.79%20.95%54.78%52.6%169.29%894.02%-
EBITDA175.32M-1.59B-406.54M229.88M188.15M320.29M320.13M486.58M452.52M320.41M25.26M58.4M75.96M62.9M107.46M-694.95M446.6M354.64M220.23M141.62M53.3M-5.82M
EBITDA Margin %5.48%-286.37%-22.48%7.19%6.76%9.79%9.8%13.13%13.04%7.84%0.62%2.37%3.53%3.58%6.78%-45.82%36.19%30.71%26.09%31.56%21.11%-4.05%
Interest Expense5.39M3.71M0000000000002.44M05K4K95K21.91K38.99K16.15K
Non-Operating Income20.5M670.35M-404.12M000000000000-1.06B-4.6M-47.67M-47.52M000
Pretax Income348.5M-2.27B408.19M348.5M126.74M350.51M359.56M336.37M841.68M614.04M172.34M199.17M190.37M127.14M175.11M-660.06M475.79M374.63M258.3M154.33M56.75M-6.05M
Pretax Margin %10.9%-408.44%22.57%10.9%4.56%10.72%11%9.08%24.25%15.02%4.22%8.1%8.85%7.24%11.04%-43.52%38.56%32.44%30.61%34.39%22.47%-4.21%
Income Tax59.4M4.02M98.72M59.4M41.02M90.57M83.39M143.82M224.59M167.8M27.25M25.55M24.29M27.16M50.37M84.03M89.13M95.62M62.44M3.19M-584.81K670.1K
Effective Tax Rate %17.05%-0.18%24.18%17.05%32.36%25.84%23.19%42.76%26.68%27.33%15.81%12.83%12.76%21.36%28.77%-12.73%18.73%25.52%24.17%2.06%-1.03%-11.08%
Net Income280.48M-2.28B454.96M280.48M100.27M250.99M268.25M188.93M609.91M449.23M157.05M210.09M161.76M95.64M130.51M-299.37M422.31M300.84M191.74M153.57M58.79M-6.69M
Net Margin %8.77%-408.83%25.15%8.77%3.6%7.67%8.21%5.1%17.57%10.99%3.85%8.54%7.52%5.44%8.23%-19.74%34.22%26.05%22.72%34.22%23.28%-4.66%
Net Income Growth %179.72%-600.13%62.21%179.72%-60.05%-6.44%41.98%-69.02%35.77%186.05%-25.25%29.88%69.13%-26.72%143.59%-170.89%40.38%56.9%24.85%161.21%978.44%-
EPS (Diluted)52.40-224.5385.0052.0018.000.1250.0034.0098.0072.0026.0034.0032.0020.0026.00-59.8085.2064.8041.8042.8717.49-2.78
EPS Growth %188.89%-364.15%63.46%188.89%14900%-99.76%47.06%-65.31%36.11%176.92%-23.53%6.25%60%-23.08%143.48%-170.19%31.48%55.02%-2.5%145.11%729.14%-
EPS (Basic)--224.5385.3152.000.050.1250.0034.0098.0072.0028.0036.0032.0020.0026.00-59.8088.2066.0042.0043.5717.65-2.78
Diluted Shares Outstanding5.35M10.13M5.35M5.38M5.37M5.37M5.37M5.47M6.2M6.31M6.04M6.02M5.06M5M5.03M5.01M4.95M4.64M4.59M3.58M3.28M2.41M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Structural Revenue Model Collapse

Revenue Contraction Signals Structural Decay

As reported in financial statements, AIFU experienced a significant 21.4% year-over-year revenue decline in 2023Q4, reflecting a broader trend of volatility that suggests the company's agency-driven distribution model is struggling to maintain its historical volume amidst shifting consumer demand and potential agent force attrition.

The consistent downward pressure on top-line figures indicates that the company's reliance on transactional, front-loaded commissions is highly sensitive to current market conditions. This trajectory suggests that the legacy distribution network may no longer be sufficient to sustain historical growth levels without a fundamental pivot.

Underwriting Profitability Under Severe Pressure

Based on the provided quarterly data, the combined ratio reached 97.3% in 2023Q4, illustrating a narrowing margin profile that leaves little room for operational error as the company attempts to navigate a transition toward an AI-integrated service model while managing rising loss ratios.

The deterioration in the combined ratio from the mid-80s range in previous periods suggests that underwriting discipline may be weakening or that claims costs are outpacing premium adjustments. Investors should monitor whether this trend reflects a permanent shift in the cost of risk or temporary operational inefficiencies.

Operating Efficiency Strained by Overhead

According to recent SEC filings, the company's inability to align its fixed cost structure with declining revenue has resulted in a net loss of $27.2 million in 2023Q4, highlighting a critical disconnect between the current scale of operations and the actual volume of business generated.

The high operating leverage inherent in maintaining a physical branch network appears to be a significant burden during this period of contraction. Without a rapid reduction in fixed administrative expenses, the company may continue to face margin compression that threatens its long-term financial viability.

Pivot Risks Masking Operational Distress

Data from the latest quarterly reports indicates that the company's aggressive pivot toward AI-driven services may be a defensive reaction to a collapsing legacy model, as evidenced by the -408% net margin and the potential for capitalized development costs to obscure underlying cash burn.

The market's focus on the AI rebranding warrants skepticism, as it may distract from the core issue of declining agent productivity and high fixed costs. It appears that the company is attempting to trade its way out of a structural decline, which may lead to further capital depletion if the new strategy fails to gain traction.

AIFU — Frequently Asked Questions

Quick answers to the most common questions about buying AIFU stock.

What was AIFU Inc.'s (AIFU) revenue in 2025?

For fiscal year 2025, AIFU Inc. (AIFU) reported total revenue of $556.6M. This represents a 287.2% increase compared to $143.7M in 2005.

Is AIFU Inc. (AIFU) profitable?

AIFU Inc. (AIFU) reported a net loss of $2.28B for the fiscal year ending 2025.

What is AIFU Inc.'s operating profit margin?

AIFU Inc. (AIFU) reported an operating income of $-1599.2M, resulting in an operating profit margin of -287.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is AIFU Inc.'s gross profit and gross margin?

AIFU Inc. (AIFU) generated $274.3M in gross profit for the year, representing a gross profit margin of 49.3%. This demonstrates the company's core pricing power and production efficiency.